Danaher Reports Second Quarter 2026 Financial Results

Danaher Corporation announced its financial results for the second quarter of 2026, reporting net earnings of $870 million, or $1.23 per diluted common share, a 60% increase year-over-year. Non-GAAP adjusted diluted net earnings per common share grew by 8.0% to $1.94. Total revenues increased by 5.5% to $6.3 billion, with non-GAAP core revenue up 3.0% year-over-year. The company generated $1.5 billion in operating cash flow and $1.3 billion in non-GAAP free cash flow. Danaher is increasing its full-year 2026 adjusted diluted net earnings per common share guidance to a range of $8.45 to $8.60. The company also announced its intention to acquire StatLab, a manufacturer of histology workflow products, for approximately $250 million in revenue, expecting it to be accretive to earnings in its first full year. The acquisition is anticipated to close by the end of 2026, subject to regulatory approvals.